All Activity

Great Publish, I'm a large believer within publishing remarks upon websites in order to allow weblog authors realize that they’ve additional some thing beneficial in order to the internet! link slot

I’m prompted while using the surpassing in addition to preachy checklist you give in such very little timing. Is John Spencer Ellis an expert in marketing?

In-app messages under the promo section list all active offers, while advertisements during major events embed codes. 1xbet promo code bd

A promotional code from 1 x bet will be presented to you to receive an increased 1xbet welcome bonus promo code. Using a bonus when allows you to get up to 100% on your first deposit and use it on bets on your favorite sporting events or a bonus offer on the first 5 deposits for gambling and also 1xbet promo code free spins. 1xbet free bet promo code

The 1xBet promo code: New888, represents more than a mere activation string—it's a strategic enhancer in the realm of digital wagering and gaming. 1xbet promo code today

Use Visa or MasterCard for traditional banking, Skrill or Neteller for e-wallets, or cryptocurrencies like BTC and ETH with no upper limits. 1xbet today promo code

When you enter a 1xBet promo code for registration, you will automatically receive an increased bonus intended for newcomers. how to use 1xbet promo code

To activate this full package, simply use 1xBet casino promo code: New888 during registration to get up to €1950 + 150 free spins across your first four deposits. 1xbet promo code

Thanks for sharing the post.. parents are worlds best person in each lives of individual..they need or must succeed to sustain needs of the family. togel online

The entire process takes less than two minutes, and 1xBet now includes a newbie progress guide in 2026 to prevent errors. Select sports or casino focus during signup, though support can assist changes later, ensuring you align the bonus with your preferred gaming style. 1xbet today promo code

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. slot gacor Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. Neurologische Praxis München Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. sociéte de recouvrement paris I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. Multi-Shot AI Video Generator Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! hbowin Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. sociéte de recouvrement marseille

Seeking an unforgettable interlude in the heart of the capital? Your chosen Russian Surat call girls is prepared to offer exceptional companionship, designed to captivate and enchant. Revel in sophisticated conversation and a charming presence, ensuring your time together is uniquely personal and incredibly satisfying, every single time.

A White House spokesperson has confirmed to Marijuana Moment that President Donald Trump is “currently expected to address marijuana rescheduling” on Thursday, though they added that “any details of this potential action until officially announced by the White House are speculation.” This comes amid a rapidly churning rumor mill about the president’s potential plans to issue an executive order directing the attorney general to proceed with a proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). Sources familiar with the administration’s planning tell Marijuana Moment that an announcement on the rescheduling move is planned for 1:30pm ET and that Trump will be surrounded by various cannabis industry and movement stakeholders when signing the order. As recently reported, the president’s executive order may also address ancillary issues related to CBD coverage through federal Medicare and a call for congressional action on cannabis banking. There are also rumors that a rescheduling decision will be coupled with presidential clemency, though the scope of that potential relief is unclear. That said, the White House spokesperson made clear that the deluge of details about the administration’s plans are speculative for now. But according to NBC News, the executive order may contain an explicit push from the president urging Congress to pass a bipartisan bill titled the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which would prevent federal regulators for penalizing financial institutions simply for working with state-licensed marijuana businesses. The lack of banking access for the cannabis industry was also raised in a Senate subcommittee hearing on Tuesday. It’s also being speculated that the plan is to take a novel—albeit logistically complicated—approach to cannabidiol, a non-intoxicating component of the cannabis plant that’s widely used as a health supplement. Sources have said that drafts of the executive order have called on the Centers for Medicare and Medicaid Services (CMS) to amend its rules to let people on Medicare receive reimbursements for the cannabinoid product. That potential reform was also floated in a video from The Commonwealth Project touting the health benefits of CBD that Trump shared on Truth Social in late September. CMS implemented a rule in April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services. But the agency has since revised the proposed rule, just weeks before the expected administrative order by Trump. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. The post White House Confirms Trump Will ‘Address Marijuana Rescheduling’ Thursday, But Reported Details On Final Decision Are ‘Speculation’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

As President Donald Trump prepares to announce a decision on marijuana rescheduling, a new poll from a religious conservative research firm again shows that a majority of Americans are ready for legalizing cannabis altogether. Trump voters, however, are largely not on board with the change—with the exception of younger ones. The survey—conducted by YouGov on behalf of the Ethics and Public Policy Center (EPPC)—was detailed in a post published by one of the organization’s lead researchers on his Family Matters blog last week. Overall, it found that 57 percent of respondents either “somewhat” or “strongly” support cannabis legalization. A demographic breakdown of age and political affiliation showed some familiar divides on the issue, with a majority of people aged 46 and older who voted for Trump in the last election (53 percent) oppose legalization. However, a 49 percent plurality of Trump voters 18-45 said they do back the reform. Among people who voted for former Vice President Kamala Harris in the last election, however, there was a somewhat unusual finding: More people in the older cohort (87 percent) said they support legalization than those in the younger cohort (71 percent). A majority of Republicans oppose marijuana legalization, with even young GOP voters are pretty split, and those with kids really don't like it. Rescheduling pot will make young men worse off — and it won't save the GOP in next year's midterms, either: https://t.co/gQR3o3S0rF https://t.co/scEFw0PdQc pic.twitter.com/ubWbgQr7X0 — Patrick T. Brown (@PTBwrites) December 12, 2025 Asked about the net effect of legalization on society, 68 percent of younger Harris voters said it leads to “more social benefits than costs,” and an even larger majority (82 percent) of older Harris voters said the same. By contrast, a majority of both younger and older Trump voters (59 percent and 67 percent, respectively) said legalization is associated with “more social costs than benefits.” Adults 18-45 without children were more supportive of ending prohibition at 60 percent, compared to 52 percent who are parents, the poll found. “This offers a sketch for what a new political coalition interested in curbing the excesses of our rapid entry into a world of widespread medical marijuana might look like,” EPPC’s Patrick Brown said, adding that if the Trump administration does move to reschedule marijuana, “conservatives and well-meaning liberals shouldn’t accept a new reality of capitalism-fueled marijuana availability without a fight.” “The concerns about what widespread weed could mean for children’s health—and young adults’ long-term outcomes—won’t have gone away, regardless of the profit motives involved,” he said. While this poll does show a partisan split on the issue with most Republicans against legalization, other independent surveys over recent years have signaled that ending prohibition is an increasingly bipartisan issue. That said, support among GOP voters dipped somewhat over the last year, according to a recent Gallup poll. A separate research firm associated with Trump survey of registered voters did recently show that a majority of Republicans back a variety of cannabis reforms, including rescheduling, states’ rights to legalize and marijuana industry access to banking services and stock exchanges. Sources familiar with the administration’s potentially imminent decision on marijuana reform haven’t been suggesting that the president intends to legalize marijuana, however. The proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) would mean it’d still be federally prohibited. But marijuana businesses could then start taking federal tax deductions, and it could help reduce certain research barriers associated with Schedule I drugs. There was also reporting this week indicating that the executive order on rescheduling that the president is expected to issue may also contain additional components touching on cannabis business banking access and Medicare coverage for CBD. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — or what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Photo courtesy of Mike Latimer. The post Most Americans Back Legalizing Marijuana, But Trump Voters Not On Board, Conservative Group’s Poll Shows Amid Rescheduling Rumors appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Sen. Cory Booker (D-NJ) and Rep. Eleanor Holmes Norton (D-DC) have filed a bill in Congress to allow people living in federally assisted housing to use marijuana in compliance with state laws without having to fear losing their homes. Under current policy, people who live in public housing are prohibited from using controlled substances in those facilities regardless of state law, and landlords are able to evict them. The new bicameral legislation—titled the “Marijuana in Federally Assisted Housing Parity Act”—would change that. The bill would provide protections for people living in public housing or Section 8 housing from being displaced simply for using cannabis in states that have legalized it for medical or recreational purposes. Norton has filed similar versions of the proposal over recent sessions, but the reform has yet to be enacted. Booker joined Norton in sponsoring the legislation last Congress as well. “Tenants should not be discriminated against, evicted, or denied federally assisted housing for legally using marijuana or treating a medical condition in states where it is permitted,” Booker said in a press release on Wednesday. “The Marijuana in Federally Assisted Housing Parity Act would end these discriminatory practices and ensure tenants are not punished for personal choices made in accordance with state law.” The bill would further require the head of the U.S. Department of Housing and Urban Development (HUD) to enact regulations that restrict smoking marijuana at these properties in the same way that tobacco is handled. “Individuals living in federally funded housing should not fear eviction simply for treating their medical conditions or for seeking a substance legal in their state,” Norton said. “Increasingly, Americans are changing their views on marijuana, and it is time that Congress caught up with its own constituents. With so many states improving their laws, this issue should have broad bipartisan appeal because it protects states’ rights.” Marijuana is legal in 40 states, yet people in federally funded housing can still be evicted for using it. I introduced a bill with @SenBooker to fix this and align federal law with the 90% of Americans who support legal medical marijuana. pic.twitter.com/tR0ZjTyXYT — Eleanor #DCStatehood Holmes Norton (@EleanorNorton) December 17, 2025 In 2018, a Trump administration official said that she was working to resolve conflicting federal and state marijuana laws as it applies to residency in federally-subsidized housing, but it’s not clear what came of that effort. Norton sent a letter to HUD in 2021 that implored the department to use executive discretion and not punish people over cannabis in legal states. In response, the President Joe Biden’s HUD secretary told the congresswoman that it is statutorily required to continue denying federally assisted housing to people who use marijuana, even if they’re acting in compliance with state law. Booker and Rep. Maxwell Alejandro Frost (D-FL) filed a bill last year to repeal a decades-old federal statute that’s led to the denial of housing for millions of people with prior drug convictions. — Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Rep. Alexandria Ocasio-Cortez (D-NY) also raised the issue during a committee hearing in 2019, pressing former HUD Secretary Ben Carson on policies that cause public housing residents and their families to be evicted for committing low-level offenses such as marijuana possession. Ocasio-Cortez and then-Sen. Kamala Harris (D-CA) also filed legislation that year that would protect people with low-level drug convictions from being denied access to or being evicted from public housing. Sen. Jeff Merkley (D-OR) also introduced an affordable housing bill in 2020 that included a provision to prevent landlords from evicting people over manufacturing marijuana extracts if they have a license to do so. The post New Congressional Bill Would Let People Use Marijuana In Public Housing Without Being Evicted appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Cannabis industry observers believe it is increasingly likely that President Donald Trump will soon sign an executive order directing federal agencies to complete the marijuana rescheduling process. But multiple reports indicate that the directive could also contain additional components touching on cannabis business banking access and Medicare coverage for CBD. The exact details of the executive order aren’t clear, but White House sources seem to be coalescing around the idea that it will be signed on Thursday and will instruct the Justice Department to proceed with plans to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). A source familiar with fluid discussions around the administrative action also told Marijuana Moment that Trump may couple the presidential directive with clemency for some people who have been convicted over federal marijuana offenses. Neither that plan, nor the reported details about cannabis banking or CBD and health care, have yet been confirmed, however. According to NBC News, the potentially imminent executive order may contain an explicit push from the president urging Congress to pass a bipartisan bill titled the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which would prevent federal regulators for penalizing financial institutions simply for working with state-licensed marijuana businesses. The lack of banking access for the cannabis industry was also raised in a Senate subcommittee hearing on Tuesday. It’s also being speculated that the plan is to take a novel—albeit logistically complicated—approach to cannabinol, a non-intoxicating component of the cannabis plant that’s widely used as a health supplement. Sources have said that drafts of the executive order have called on the Centers for Medicare and Medicaid Services (CMS) to amend its rules to let people on Medicare receive reimbursements for the cannabinoid product. That potential reform was also floated in a video from The Commonwealth Project touting the health benefits of CBD that Trump shared on Truth Social in late September. CMS implemented a rule in April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services. But the agency has since revised the proposed rule, just weeks before the expected administrative order by Trump. Marijuana Moment reached out to the White House for clarification on the rumored executive order, but a spokesperson did not respond by the time of publication. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — For what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Photo courtesy of Philip Steffan. The post Trump’s Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Republican gubernatorial candidate in Maine is imploring voters not to sign a petition to put a “really dumb” initiative on next year’s ballot that would roll back the state’s adult-use marijuana legalization law. The measure, if approved, would also revise the regulatory structure of the medical cannabis program by imposing product testing requirements. “It’s dumb. It’s a dumb idea. Let’s focus on the things that really matter—the things that are going to make Maine a better place,” David Jones, a real estate executive who previously ran for governor in 2006, said. “Give law enforcement the opportunity to enforce the laws. Get rid of these illegal Chinese grows,” he said. “There’s tens of thousands of people who use cannabis. There’s people who invest their life savings [to enter the market]. This is an industry that generates over a half a billion dollars a year.” ‘I think we just have to focus on the things that make sense. And this, I’m sorry, just does not make sense,” Jones said. “So please do not sign that petition. It doesn’t make any sense. Stand with me on this, and let’s do what we can to make Maine great again.” The proposal that officials cleared for signature gathering earlier this month—“An Act to Amend the Cannabis Legalization Act and the Maine Medical Use of Cannabis Act”—is a revised version of a marijuana initiative filed in September that was backed by a Republican state senator and a former top staffer to then-Gov. Paul LePage (R), a staunch prohibitionist. If the latest measure makes the ballot and gets approved, it would remove and amend multiple sections of current state statute—aimed at effectively repealing the legalization of recreational marijuana sales that voters passed in 2016. Possession of up to 2.5 ounces of cannabis by adults 21 and older would remain legal under the proposal, but a section of the law permitting home cultivation would be repealed. Medical marijuana sales and home cultivation would remain legal. Madison Carey, who was listed as the chief petitioner of the original version of the repeal initiative and remains involved in the current campaign, told Marijuana Moment last week that “there needs to be regulations on marijuana,” arguing that her experience recovering from an opioid misuse disorder speaks to the insufficiency of current law. “My hope is to just bring awareness to the reality of the potential dangers of not having regulations,” she said. “I think people are fed up with the constant use—the constant [retail businesses] coming up where people can now legally purchase marijuana.” Of course, repealing the voter-approved law that enacted a system of licensed adult-use sales would eliminate the current regulatory infrastructure that’s in place, which reform advocates argue helps mitigate the public health and safety risks associated with the illicit market. Rep. David Boyer (R), who led the fight to pass the cannabis legalization initiative on Maine’s ballot in 2016 when he was a staffer for the Marijuana Policy Project, said voters should refuse to sign petitions for the new initiative. “Don’t sign away Maine’s progress—decline to sign this misguided repeal initiative,” he told Marijuana Moment last week. “Repealing cannabis legalization would shutter an industry bigger than lobsters, potatoes and blueberries put together, costing jobs, revenue and economic growth for our state.” Under the new measure, the director of the Office of Cannabis Policy would face a mandate to “promote the health and well-being of the people of the state and advance policies that protect public health and safety, emphasizing the health and well-being of minors, as priority considerations in performing all duties.” They would also have to “ensure that qualifying patients maintain access to high-quality, effective and affordable cannabis for medical use under this Act.” Under the proposal, the Department of Administrative and Financial Services would be required to create a testing program for cannabis products, requiring dispensaries and caregivers to submit such products to a licensed facility for a safety assessment before they’re distributed to qualified patients. The testing facility would need to “ensure that the cannabis or cannabis product does not exceed the maximum level of allowable contamination for any contaminant that is injurious to health and for which testing is required and to ensure correct labeling.” “The department shall adopt rules establishing a testing program pursuant to this section, rules identifying the types of contaminants that are injurious to health for which cannabis and cannabis products must be tested under this chapter and rules regarding the maximum level of allowable contamination for each contaminant,” the ballot initiative text states. Further, regulators would need to administer a system for tracking cannabis plants from seedings to the point of retail sale or disposal. That system would have to “allow for cannabis plants at the stage of cultivation and upon transfer from the stage of cultivation to another registrant to be tracked by group.” Activists must submit at least 67,682 valid voter signatures by February 2, 2026 in order to qualify for next year’s ballot. If approved by voters, the initiative would take effect beginning on January 1, 2028. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Maine legislators in June rejected a bill to legalize possession of up to one ounce of psilocybin by adults 21 and older. That followed a separate effort in the state last year to legalize psilocybin and allow adults to access the psychedelic at state-licensed facilities. But lawmakers watered down that bill—amending it to create a commission to further explore the reform instead—and it ultimately did not pass. Meanwhile, Maine lawmakers in February voted to investigate possible conflicts of interest by a top marijuana official. And last year, a law took effect allowing people to apply to have records of now-legal marijuana crimes sealed. Photo courtesy of Chris Wallis // Side Pocket Images. The post Maine Initiative To Roll Back Marijuana Legalization Is ‘Really Dumb,’ GOP Gubernatorial Candidate Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A GOP congressman says President Donald Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Rep. Andy Harris (R-MD)—a staunch prohibitionist who recently helped secure provisions in a spending bill Trump signed that would effectively recriminalize hemp—shared his views about the marijuana rescheduling proposal and limitations of a Schedule III reclassification under the Controlled Substances Act (CSA) on Tuesday during a webinar organized by the National Drug and Alcohol Screening Association (NDASA). Harris adamantly opposes the potential rescheduling action, arguing that it would further normalize marijuana use and do little to expand research opportunities to examine the plant’s health benefits or risks. And he said the president was mistaken when he said on Monday that reclassification is necessary to conduct the research. The congressman also argued that Trump is “technically” wrong if he’s under the impression he can move marijuana from Schedule I to Schedule III with a stroke of the pen on an executive order. Rescheduling wouldn’t legalize marijuana, but it’d be a historically symbolic recognition that cannabis holds medical value, while enabling marijuana businesses to take federal tax deductions available to other industries. “He can tell any agencies to make every effort” by executive order Harris acknowledged, “but I’m not sure that it’s legal for the president to do it.” “Obviously the executive branch can do it without congressional input. We could always override it, but that would be a heavy lift,” he said. Harris also touted the fact that he’s “led the charge against recreational marijuana in the District of Columbia for over 10 years,” primarily by ensuring the continuing annual renewal of an appropriations rider barring Washington, D.C. from using its tax dollars to legalize marijuana sales, despite voters approving legalization over a decade ago. “I don’t believe that it’s a safe drug to have out there,” he said, adding that the process of getting a medical marijuana recommendation that permits access at the state level is a “scam” and “we don’t really need to reschedule it.” While the president said a Schedule III reclassification would bolster research into cannabis, Harris said he’s worked across the aisle with Democrats such as former Rep. Earl Blumenauer (D-OR), a key champion of legalization, to address the study barriers issue through separate legislation they passed and which was signed into law by President Joe Biden. Blumenauer “thinks that if you do all the research, you’re going to show all these great things marijuana does medically,” Harris said. “I think, if you do the research, you’ll find out there’s very little that marijuana is actually a first-line or even a second-line drug.” “To use doing research as an excuse to go from schedule one to schedule three is just not fair. It’s not accurate. You can do all the research you want on Schedule I,” he said. However, that’s not strictly true, as researchers interested in studying Schedule I drug must obtain Drug Enforcement Administration (DEA) approval to use or import those substances and follow other more stringent reporting requirements that even the head of the National Institute on Drug Abuse (NIDA) has described as excessively burdensome. “We have to join arms in this and say, rescheduling ‘is just not right’ and ‘not a good decision for the health of America,'” Harris said. “That’s the bottom line. I think there is no evidence that it’s good, and there’s plenty of evidence now that chronic use of marijuana—especially in teenage years, especially before the brain is fully formed—is probably just a bad idea, and encouraging in any way, shape or form, such as reducing the scheduling, just has no basis in science or medical fact.” “I’m hoping that there is some pushback from within the administration by calmer, cooler heads saying, ‘time out—let’s think this through very carefully. Let’s get the experts in from the administration.’ And I don’t mean the marijuana industry, because we know their famous meetings with the president, with people who make a lot of money in that industry. I mean the scientists like [NIDA Director Nora Volkow] to sit down and to talk some sense into the people who would otherwise consider this.” Meanwhile, another GOP congressman said on Monday that Trump would be “wrong” to move forward with the plan to reschedule marijuana, which he described as a “gateway drug” that leads to the use of “harder substances”—despite numerous studies contradicting that theory. Though speculation about an imminent action has been swirling this month, it remains to be seen whether Trump will ultimately fulfill his campaign promise to move cannabis to Schedule III. He endorsed the reform—as well as industry banking access and a Florida adult-use legalization initiative—on the campaign trail last year. But he’s since been largely silent on the issue since taking office during his second term, unless prompted by reporters. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Cannabis industry stakeholders are holding out hope that the reform will be achieved as soon as possible, but opponents—including NDASA and Smart Approaches to Marijuana (SAM)—are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Photo courtesy of Philip Steffan. The post GOP Congressman Says Trump ‘Technically’ Can’t Reschedule Marijuana On His Own, But Reversing It In Congress Would Be A ‘Heavy Lift’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I read that Post and got it fine and informative. led mirror manufacturer I read that Post and got it fine and informative. olxtoto I read that Post and got it fine and informative. agence événementielle tunisie

La vérification d’identité peut être exigée pour garantir la sécurité. code promo melbet haïti

Plus rarement, un code promo prend la forme d'un mot ou d'une phrase liée à un bookmaker ou à une date importante. code promo melbet burkina faso

Bill targets online marijuana ads; Senator attends hemp biz opening; GOP lawmaker: Cannabis a “gateway drug”; Prohibitionist filing in SCOTUS gun case Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Senate Banking Subcommittee on Financial Institutions and Consumer Protection took testimony on marijuana businesses’ financial services access problems—with Nevada’s former top cannabis regulator saying the issue makes state officials’ jobs harder. The House Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade approved a bill called the Kids Online Safety Act that would require online platforms to take steps to prevent minors’ access to potentially sensitive content—including advertisements for cannabis products and certain other drugs and services. Sen. Rand Paul (R-KY) attended a ribbon cutting ceremony at a new hemp store, saying he’s “working on new legislation” to reverse the looming federal recriminalization of THC products that was signed into law by President Donald Trump. Rep. Mike Lawler (R-NY) said President Donald Trump would be “wrong” to reschedule marijuana—calling it a “gateway drug.” Smart Approaches to Marijuana and other prohibitionist groups filed a brief asking the Supreme Court to uphold the law banning gun possession by cannabis consumers—alleging that marijuana is more dangerous than alcohol and makes people more prone to psychosis and violence despite it being “marketed as a ‘chill’ drug by its peddlers.” A study of Olympic and elite-level athletes found that “CBD users cumulatively agreed or strongly agreed that CBD is safe (96%); improved sleep (93%) and relaxation (90%); and reduced pain from training (77%).” “Many athletes expressed concerns about the potential for inadvertent anti-doping rule violations due to CBD product contamination with THC or other banned cannabinoids.” The Missouri Division of Cannabis Regulation is proposing changes to rules for marijuana social equity microbusinesses in order to address “predatory” contracts that have led to the revocation of previously awarded licenses. / FEDERAL White House Chief of Staff Susie Wiles said former Department of Government Efficiency head Elon Musk is “an avowed ketamine [user]” and then denied saying it despite a reporter recording it on tape. The U.S. Sentencing Commission is accepting public comments on proposed amendments to federal sentencing guidelines. Rep. Dina Titus (D-NV) discussed momentum for marijuana policy reform. The House bill to create a path for patients to use Schedule I drugs got two new cosponsors for a total of nine. / STATES A New Mexico cannabis company CEO launched a gubernatorial campaign as a Republican. Florida’s attorney general tweeted, “We are seeing a rise in the dangerous consequences of marijuana use on young people. As ER visits go up, my office will be investigating how these products are getting into kids’ hands.” Kansas’s attorney general reacted to a lawsuit challenging recent raids on sellers of allegedly illegal cannabis products. Nebraska’s attorney general said the federal recriminalization of hemp THC products is a “very significant win for the country.” The New Jersey Senate Budget and Appropriations Committee approved a bill to restrict hemp products. An Ohio representative discussed his reasons for voting against a bill to alter the voter-approved marijuana legalization law and institute restrictions on hemp products. New York regulators published updated marijuana packaging, labeling and marketing rules. Maryland regulators filed proposed changes to cannabis tax rules. Colorado regulators published guidance on changes to marijuana rules. Vermont regulators will consider marijuana purchase limits guidance, multi-dose gummies and other issues on Wednesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Boston, Massachusetts Cannabis Board will meet on Wednesday. / INTERNATIONAL Khyber Pakhtunkhwa, Pakistan’s government is moving to legalize cannabis cultivation. / SCIENCE & HEALTH A study found that “CBD has therapeutic potential in the treatment of [autism spectrum disorder] symptoms, especially behavioral and emotional problems.” A study found “positive feedback regarding CBD’s use for insomnia, indicating that most users perceive it as an effective treatment for this condition.” A review concluded that “cannabinoids, especially CBD, exhibit significant potential as adjuvant or alternative treatments for inflammatory, infectious, and autoimmune skin diseases.” / ADVOCACY, OPINION & ANALYSIS Colorado Leads, American Trade Association for Cannabis and Hemp), Massachusetts Cannabis Coalition and Nevada Cannabis Association filed an amicus brief in a U.S. Tax Court case challenging the 280E penalty on marijuana businesses. / BUSINESS Organigram Global Inc. reported quarterly net revenue of C$80.1 million and a net loss of C$38.0 million. Michigan retailers sold $259.7 million worth of legal marijuana products in November. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Cannabis banking issues debated in Senate committee (Newsletter: December 17, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! spotbet Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. spotbet I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. spotbet Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. spotbet Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. spotbet Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. spotbet Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. Slot 10k Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! togel 4d

Les free spins du casino doivent être utilisés sous 24 heures, mais l’ensemble du pack reste soumis à la fenêtre globale de 30 jours. code promo melbet telegram algérie

Si des données fausses sont fournies, le compte peut être bloqué définitivement. le meilleur code promo melbet